BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25227934)

  • 1. Progressive multifocal leukoencephalopathy therapy.
    Clifford DB
    J Neurovirol; 2015 Dec; 21(6):632-6. PubMed ID: 25227934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
    Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
    Front Immunol; 2019; 10():1188. PubMed ID: 31191548
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.
    Schröder A; Lee DH; Hellwig K; Lukas C; Linker RA; Gold R
    Arch Neurol; 2010 Nov; 67(11):1391-4. PubMed ID: 20625069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
    Tan CS; Koralnik IJ
    Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
    Harypursat V; Zhou Y; Tang S; Chen Y
    AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy: new concepts.
    Lima MA
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
    Cortese I; Reich DS; Nath A
    Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
    N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
    Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
    Shishido-Hara Y
    Neuropathology; 2015 Oct; 35(5):487-96. PubMed ID: 25946231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the management of PML: focus on natalizumab.
    Fox R
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy treated with nivolumab.
    Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
    J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations.
    Soni N; Ora M; Mangla R; Singh R; Ellika S; Agarwal A; Meyers SP; Bathla G
    Mult Scler Relat Disord; 2023 Sep; 77():104830. PubMed ID: 37418930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
    Clifford DB; De Luca A; Simpson DM; Arendt G; Giovannoni G; Nath A
    Lancet Neurol; 2010 Apr; 9(4):438-46. PubMed ID: 20298967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on progressive multifocal leukoencephalopathy.
    Steiner I; Berger JR
    Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of progressive multifocal leukoencephalopathy and natalizumab.
    Aksamit AJ
    Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
    Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A
    Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.